Navigation Links
Lumenis Introduces the HoLEP Simulator and the PolyScope Disposable Ureteroscope at American Urology Association 2009 Annual Meeting
Date:4/22/2009

SANTA CLARA, Calif., April 23 /PRNewswire/ -- Lumenis Inc., a subsidiary of Lumenis Ltd., a global developer, manufacturer and seller of laser, light-based and radiofrequency devices for surgical, aesthetic, and ophthalmic applications, announced today at the American Urological Association's (AUA) annual show the introduction of a Holmium Laser Enucleation of the Prostate (HoLEP) training simulator and the PolyScope Disposable Ureteroscope(1), a new flexible scope with enhanced vision and flexibility. These items support Lumenis' continued commitment to new technology and training that advance the medical laser community.

Computer-Guided Interactive HoLEP Simulator

The abundance of clinical evidence suggests that HoLEP provides superior outcomes and long term durability in treating Benign Prostatic Hyperplasia (BPH) of all gland sizes(2). There has been increasing interest from physicians to learn HoLEP. Dr. James Lingeman, Clinical Professor of Urology, Indiana University School of Medicine, stated, "The HoLEP simulator is the future of surgical training. This learning approach allows physicians to practice the procedure and first achieve a standard level of competence before operating live. This new training technology will benefit physicians and patients alike."

There is a body of clinical evidence that shows that HoLEP provides superior treatment outcomes and is durable long-term. The training simulator is an effective tool that allows more physicians to be trained on the HoLEP procedure. "The clinical data supporting the superiority of the HoLEP procedure is significant," says Mr. Dov Ofer, Chief Executive Officer of Lumenis. "Lumenis is committed to providing the state-of-the-art training tools so that more urologists can become proficient with the HoLEP procedure and make it available to patients worldwide."

HoLEP is performed using Lumenis' VersaPulse(R) PowerSuite(TM) l
'/>"/>

SOURCE Lumenis Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Lumenis(R) Introduces the Newest Innovations in Fractional CO2 Laser Skin Therapy
2. Lumenis Ltd. Announces Senior Leadership Appointments Strengthening the Companys Strategic Businesses
3. Alma Lasers Answers Lumenis Complaint
4. Lumenis(R) Seeks Shareholder Approval of Proposed Class Action Settlement
5. Lumenis Sues Alma Lasers and its 4 founders for 200 Million Shekels
6. Lumenis Announces changes in Lumenis Vision Strategic Business Unit
7. Lumenis Launches HoLEP Preceptor Program at American Urology Association 2008 Annual Meeting
8. Lumenis(R) Introduces Four New Products & Delivery Devices at the 2008 American Academy of Ophthalmology Annual Meeting in Atlanta, Georgia USA
9. Lumenis(R) Introduces LightSheer(R) Duet(TM) for High Speed Permanent Hair Reduction
10. Lumenis(R) UltraPulse CO2 Laser to be Featured on National Television with Live Pearly Penile Papule (PPP) Procedure
11. Lumenis(R) UltraPulse CO2 Laser to be Featured on National Television with Live Pearly Penile Papules (PPP) Procedure

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)..., Nov. 27 Preventing di...d fortunately every year, new vaccines are being a...accines boost immunity for the same period of time... needed to keep immunity strong? ,, In this m...rican Academy of Pediatrics, Michael Pichichero MD...
(Date:11/27/2009)...ecedented medical, economic burdens, study predict...- The number of people with diabetes in the United...rs, a new study predicts. , That would bring th...the disease, up from 23.7 million today. , , At ...abetes will triple, the study also warns, rising f...
(Date:11/27/2009)...hree new interactive anatomy education apps from M...nd health sciences learning opportunities for iPho...m, NC (Vocus) November 27, 2009 -- Modality, Inc....ivision of Wolters Kluwer Health, today announced ...ps on the App Store. Clemente’s Anatomy, Roh...
(Date:11/26/2009)...oo heavy can lead to strains or worse , ,...be nothing wrong with stuffing your turkey full to...hing with your suitcase as you pack for holiday tr...2008 in U.S. hospital emergency rooms, doctors, of...ggage-related injuries, such as muscle strains, pu...
(Date:11/26/2009)...enton Communications announces a highly effective ...ilers struggling to make an economic recovery. , ...-- Flu fears is the type of challenge that could s...cording to Dr. David Benton, business growth exper... system – The Rfactor Intensive . “...
Breaking Medicine News(10 mins):Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Pharmacist Injects Cure for Ailing Businesses 2
...ld just be sufficient enough to erode tooth enamel...onducted by researchers at University of Iowa. So...de ate into the enamel surface, over the teeth, sa... provides protection for the exposed areas of the ...
...as a connection with obesity risks as they grow up...w study. // A team of researchers led by Sarah ... study on a group of 820 people - 403 women and 41..., and were in the age group of 28 to 40 when the l...
...ren deteriorate as they progress through puberty, ...iversity of Alberta//. The levels of insulin, howe...rts. The study highlights this specific phase of g... Ball and his fellow researchers. Different aspect...
... India is crowned as the diabetic capital. Hence h...national programme for prevention and control of c...aid this in the Lok Sabha election meeting. He...to reduce the adverse impact of heart diseases, st...
...nd spam analysis centers, have warned users not to...the internet.// This letter claims that lipsti...rands of lipstick contain a dangerously high level...delete the email, and not forward it onto their fr...
...n reduce the incidence of pregnancy complications,... a study published by American Journal of Obstetri...elated complication characterized by elevated bloo...ion can worsen further resulting in seizures. Unde...
Other Medicine News:Health News:Tooth Enamel Eaten Away By Popular Drinks 2Health News:African American Children More Pone to Develop Diabetes 2
(Date:11/25/2009)...25 Heska Corporation ( H...diagnostic and specialty products to the veterinar...Diagnostics Corporation for the supply of blood ga...rinary market. ,, (Logo: http://www.newsco...ka and Roche share the same passion for innovating...
(Date:11/25/2009)...-BioTrendsResearchGroup,Inc.releasedWave1ofits La...i-phasesyndicatedmarketresearchprojecttrackingthel...aunchthroughthefirstsixmonthsofavailability.Eachwa...uniqueDermatologistsandqualitativeinformationfroma...staclestouse,typicalpatienttypes,productperception...
(Date:11/25/2009).... 25 Regado Biosciences, a private...ombotic aptamers with active control agents, annou...l be presenting at the Piper Jaffray 21st Annual H... in New York City. Dr. Mazzo,s presentation will ...d will include an overview of the Company,s pipeli...
Breaking Medicine Technology:Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Study to Investigate AHCC and the Swine Flu Virus 47555 1Study to Investigate AHCC and the Swine Flu Virus 47555 2Go Red For Women 28R 29 Launches 12 Week Program to Improve Heart Health and Save Lives 47553 1Go Red For Women 28R 29 Launches 12 Week Program to Improve Heart Health and Save Lives 47553 2Go Red For Women 28R 29 Launches 12 Week Program to Improve Heart Health and Save Lives 47553 3Consumer Reports 3A Hearing Aid Shoppers Pay High Prices Get Mediocre Fittings 47551 1Consumer Reports 3A Hearing Aid Shoppers Pay High Prices Get Mediocre Fittings 47551 2Consumer Reports 3A Hearing Aid Shoppers Pay High Prices Get Mediocre Fittings 47551 3Consumer Reports 3A Hearing Aid Shoppers Pay High Prices Get Mediocre Fittings 47551 4
...lly relevant model of,normal human skin found that...g the cytotoxic effect of erlotinib * Phase I sing...generally well,tolerated in metastatic melanoma pa...nventional vincristine , SOUTH SAN FRANCISCO, Cali...ces (Nasdaq:HNAB), a biopharmaceutical company foc...
... – Genta,Incorporated (Nasdaq: GNTA) announc...ical trial of its marketed product, Ganite®,(g...®;,Genentech/IDEC) and dexamethasone in patien... lymphoma (NHL). The data were,presented at the an...ncology (ASCO) in Chicago, IL. , ,Previously publi...
Other Medicine Technology:Hana Biosciences Presents Data On Two Programs At the American,Society of Clinical Oncology Annual Meeting 2Hana Biosciences Presents Data On Two Programs At the American,Society of Clinical Oncology Annual Meeting 3Hana Biosciences Presents Data On Two Programs At the American,Society of Clinical Oncology Annual Meeting 4Hana Biosciences Presents Data On Two Programs At the American,Society of Clinical Oncology Annual Meeting 5Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 2Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 3Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 4Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 5
Acuvue Toric
Binocular Loupes
Near Functional Acuity - Fact101
Near Point Card/Newspaper 8 to 48 - BC2203
Medicine Products: